Prostate cancer remains one of the leading causes of death in men. In 2015, an estimated 221,000 new cases of prostate cancer will be diagnosed and 28,000 men will die from prostate cancer. Although the incidence of prostate cancer has remained unchanged over the last 25 years, the mortality has decreased by 40+%; this is largely due to the introduction of prostate cancer screening in the early 1990’s. Before screening began, 75% of men presented with cancer spread outside the prostate gland. With screening and earlier detection, fewer than 15% of men present with extension outside the prostate. Prostate cancer screening includes a prostate exam and a blood test called the psa (prostate specific antigen). It is important to note that symptoms do not exist with early stage prostate cancer. However, as simple and relatively inexpensive as the screening is, confusion and debate exists over prostate cancer screening.